Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and betadex

9,10-dimethyl-1,2-benzanthracene has been researched along with betadex in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berta, GN; Carlotti, ME; Cavalli, R; Di Carlo, F; Di Scipio, F; Marinos, LM; Salamone, P; Sapino, S; Sprio, AE1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and betadex

ArticleYear
Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of resveratrol complexed with 2-hydroxypropyl-beta-cyclodextrin.
    Oral oncology, 2010, Volume: 46, Issue:1

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anticarcinogenic Agents; beta-Cyclodextrins; Carcinogens; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Cheek; Cricetinae; Drug Combinations; Mesocricetus; Mouth Neoplasms; Pharmaceutical Vehicles; Resveratrol; Stilbenes

2010